The Enterprise Value as of December 2025 (TTM) for GeneReach Biotechnology Corp. (4171.TWO) is 1.32B

According to GeneReach Biotechnology Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.32B. This represents a change of -7.15% compared to the average of 1.43B of the last 4 quarters.

GeneReach Biotechnology Corp. (4171.TWO) Historical Enterprise Value (quarterly & annually)

How has 4171.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of GeneReach Biotechnology Corp. over the last ten years is 3.00B. The current 1.32B Enterprise Value has changed 4.31% with respect to the historical average. Over the past ten years (40 quarters), 4171.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 3.05B. The Enterprise Value was at its lowest in in the September 2025 quarter at 1.14B.

GeneReach Biotechnology Corp. (4171.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GeneReach Biotechnology Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GeneReach Biotechnology Corp. (4171.TWO) Average Enterprise Value

How has 4171.TWO Enterprise Value performed in the past?

The current Enterprise Value of GeneReach Biotechnology Corp. (4171.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GeneReach Biotechnology Corp. (4171.TWO) Enterprise Value vs. Peers

How is 4171.TWO’s Enterprise Value compared to its peers?

GeneReach Biotechnology Corp.’s Enterprise Value is less than Great Novel Therapeutics Biotech & Medicals (1.38B), less than Enimmune corporation (1.43B), greater than NaviFUS Corp. (1.27B), greater than MegaPro Biomedical Co., Ltd (919.90M), greater than Bio Preventive Medicine Corp. (921.80M), less than BiOptic Inc. (1.34B), greater than LabTurbo Biotech Corporation (718.70M), less than Lukas Biomedical Inc. (1.38B), less than NeoCore Technology Co., Ltd. (1.65B), less than Excelsior Biopharma Inc. (1.60B),

Build a custom stock screener for GeneReach Biotechnology Corp. (4171.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneReach Biotechnology Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GeneReach Biotechnology Corp. (4171.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GeneReach Biotechnology Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.